Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Search Evidence

Wla
All
All (none selected)
Filters:
MSK
# PMID Evidence Tag
Evidence
Subspecialty
Complexity
Importance
PDF
1 32391934
FitzGerald JD 2020
2020 American College of Rheumatology Guideline for the Management of Gout. MSK
E
  PDF
2 32224772
Jirapinyo C 2020
Cleidocranial Dysplasia: Management of the Multiple Craniofacial and Skeletal Anomalies. MSK
E
3 31696858
Al-Shebani T 2019
A case of advanced chronic kidney disease with severe hypocalcemia, how to safely manage and dialyze? MSK
E
4 30888546
Messiah S 2019
Neurogenic Claudication: a Review of Current Understanding and Treatment Options. MSK
E
5 29666777
Latef TJ 2018
Injury of the Radial Nerve in the Arm: A Review. MSK
E
  PDF
6 26295653
McCarville MB , AJR 2015
Distinguishing Osteomyelitis From Ewing Sarcoma on Radiography and MRI. MSK
E
  PDF
7 25591199
Lurio JG 2015
Recognition and management of motor delay and muscle weakness in children. MSK
M 1
D
8 25861975
Bowness P. 2015
HLA-B27. MSK
E
9 27407238
Żuber Z 2015
Prevalence of HLA-B27 antigen in patients with juvenile idiopathic arthritis. MSK
E
  PDF
10 25591183
Hainer BL 2014
Diagnosis, treatment, and prevention of gout. MSK
M 1
D
11 25392987
Kydd AS , COCHD 2014
Uricosuric medications for chronic gout. MSK
M 1
D
12 25314636
Seth R , COCHD 2014
Allopurinol for chronic gout. MSK
D
  PDF
13 24717015
Krasselt M 2014
The current relevance and use of prednisone in rheumatoid arthritis. MSK
E
14 24717015
Krasselt M 2014
The current relevance and use of prednisone in rheumatoid arthritis. MSK
E
15 24323670
Cheung JP 2014
Current management of acute scaphoid fractures: a review. MSK
M 1
D
16 24672199
Sharma S 2014
Obesity: Friend or foe for osteoporosis. MSK
E
  PDF
17 24877127
Bugatti S 2014
B cells in rheumatoid arthritis: from pathogenic players to disease biomarkers. MSK
M 1
D
  PDF
18 25053890
Ireland PJ 2014
Optimal management of complications associated with achondroplasia. MSK
D
  PDF
19 23508630
Eyre DR 2013
Bone collagen: new clues to its mineralization mechanism from recessive osteogenesis imperfecta. MSK
E
  PDF
20 24018489
Muciño-Bermejo J 2013
Coagulation abnormalities in the cirrhotic patient. MSK
M 1
D
21 23085822
van Eck CF , KSSTA 2013
Methods to diagnose acute anterior cruciate ligament rupture: a meta-analysis of physical examinations with and without anaesthesia. MSK
M 1
D
22 24129145
Muratore F 2013
Discontinuation of therapies in polymyalgia rheumatica and giant cell arteritis. MSK
M 1
D
23 23858623
Ben Amor M 2013
Osteogenesis imperfecta. MSK
D
24 23728635
Shea B , COCHD 2013
Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. MSK
M 1
D
  PDF
25 23939448
Adams SM 2013
Ulcerative colitis. MSK
M 1
D
26 23253919
Tanaka Y. , ANRD 2013
Next stage of RA treatment: is TNF inhibitor-free remission a possible treatment goal? MSK
M 1
D
27 23384979
Tóth L 2013
Mechanism of the irreversible inhibition of human cyclooxygenase-1 by aspirin as predicted by QM/MM calculations. MSK
E
28 23444956
Jain A 2013
Harms of TNF inhibitors in rheumatic diseases: a focused review of the literature. MSK
M 1
D
  PDF
29 23509720
Christodoulou S 2013
Vitamin D and bone disease. MSK
M 1
D
  PDF
30 23819832
Yim SY 2013
Integrative analysis of congenital muscular torticollis: from gene expression to clinical significance. MSK
M 1
D
  PDF
31 23252132
Orrell RW. 2012
Diagnosing and managing muscular dystrophy. MSK
M 1
D
32 22543925
Ralston SH 2012
Pathogenesis of Paget disease of bone. MSK
M 1
D
33 22352734
Heard K 2012
Acetylcysteine therapy for acetaminophen poisoning. MSK
M 1
D
34 21481870
Gillani S , INJURY 2012
The effect of ischemia reperfusion injury on skeletal muscle. MSK
M 1
D
35 22593636
Maidhof W 2012
Lupus: an overview of the disease and management options. MSK
E
  PDF
36 23304190
Yoshimi R 2012
Clinical and pathological roles of Ro/SSA autoantibody system. MSK
M 1
D
  PDF
37 23145505
Byers PH 2012
Recessively inherited forms of osteogenesis imperfecta. MSK
D
38 22230308
Sinusas K. 2012
Osteoarthritis: diagnosis and treatment. MSK
D
39 22150658
Wasserman AM. 2011
Diagnosis and management of rheumatoid arthritis. MSK
M 1
D
40 22046943
Hatzenbuehler J , AFP 2011
Diagnosis and management of osteomyelitis. MSK
D
  PDF
41 21713412
Demoruelle MK 2011
Antibodies to citrullinated protein antigens (ACPAs): clinical and pathophysiologic significance. MSK
M 1
D
  PDF
42 21947177
Robinson AB 2011
Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis. MSK
M 1
D
43 21715249
Yamamoto T. 2011
Psoriatic arthritis: from a dermatological perspective. MSK
M 1
D
44 24250402
Zarghi A 2011
Selective COX-2 Inhibitors: A Review of Their Structure-Activity Relationships. MSK
D
  PDF
45 20949884
Cimino F 2010
Anterior cruciate ligament injury: diagnosis, management, and prevention. MSK
M 1
D
46 20609887
Clarke BL 2010
Physiology of bone loss. MSK
E
  PDF
47 20229973
Casey CF 2010
VItamin D supplementation in infants, children, and adolescents. MSK
M 1
D
48 20811530
Ikpeme IA 2010
Diagnosis and treatment of pyogenic bone infections. MSK
D
  PDF
49 20082510
Neal S 2010
Peripheral nerve entrapment and injury in the upper extremity. MSK
M 1
D
50 20146695
Mammen AL. 2010
Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis. MSK
M 1
D
51 20634936
Pollreisz A 2010
Diabetic cataract-pathogenesis, epidemiology and treatment. MSK
E
  PDF
52 19812535
Adrogué HJ 2009
Assessing acid-base disorders. MSK
E
53 19398486
Richette P 2009
An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition disease. MSK
D
54 19772805
Palomo I 2009
Antiphospholipid syndrome: a comprehensive review of a complex and multisystemic disease. MSK
M 1
D
55 18603024
Munoz LE 2008
Predictive value of anti-dsDNA autoantibodies: importance of the assay. MSK
M 1
D
56 18822471
Dore RK. 2008
The gout diagnosis. MSK
D
57 17133599
Farzaneh-Far A , A 2006
Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus. MSK
M 1
D
58 16939184
Nield LS 2006
Rickets: not a disease of the past. MSK
M 1
D
59 16506705
Luba KM 2006
Chronic plaque psoriasis. MSK
M 1
D
60 16515761
McHughes M 2006
Managing osteoarthritis pain when your patient fails simple analgesics and NSAIDs and is not a candidate for surgery. MSK
M 1
D
61 15864899
Ebell MH. 2005
Diagnosing rotator cuff tears. MSK
M 1
D
62 15454123
Balint GP 2004
Felty's syndrome. MSK
E
63 15226419
Ponticos M 2004
Regulation of collagen type I in vascular smooth muscle cells by competition between Nkx2.5 and deltaEF1/ZEB1. MSK
E
  PDF
64 15117015
Daniels JM 2nd 2004
Hand and wrist injuries: Part I. Nonemergent evaluation. MSK
M 1
D
65 14530779
Cervera R 2003
Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. MSK
E
66 12922961
Lee DM , ANRD 2003
Clinical utility of the anti-CCP assay in patients with rheumatic diseases. MSK
E
  PDF
67 12825844
Kiesler J 2003
The abnormal fontanel. MSK
D
68 12141705
Tsai TT 2002
Management of scaphoid nonunion with avascular necrosis using 1, 2 intercompartmental supraretinacular arterial bone grafts. MSK
M 1
D
69 11730311
Koler RA 2001
Dermatomyositis. MSK
M 1
D
70 11151713
van Ouwerkerk WJ 2000
Management of obstetric brachial plexus lesions: state of the art and future developments. MSK
E
71 11117054
Hovius SE , HANDC 2000
Volkmann's ischemic contracture. Prevention and treatment. MSK
M 1
D
72 11059539
Celayir AC. 2000
Congenital muscular torticollis: early and intensive treatment is critical. A prospective study. MSK
D
73 10892637
Noble SL 2000
Cyclooxygenase-2 enzyme inhibitors: place in therapy. MSK
M 1
D
74 11034691
Suarez-Almazor ME , COCHD 2000
Antimalarials for treating rheumatoid arthritis. MSK
E
75 10354521
Glasgow JF 1999
The mechanism of inhibition of beta-oxidation by aspirin metabolites in skin fibroblasts from Reye's syndrome patients and controls. MSK
E
76 9316557
Spencer-Green G 1997
Test performance in systemic sclerosis: anti-centromere and anti-Scl-70 antibodies. MSK
M 1
D
77 8546045
Larsen LC 1996
Management of acetaminophen toxicity. MSK
M 1
D
78 1858607
Jones JG. 1991
Ulnar tunnel syndrome. MSK
M 1
D
79 3443407
Topol LZ 1987
Interaction of promoters and oncogenes during transfection. MSK
M 1
D
80 479251
Mubarak SJ , BJJ 1979
Volkmann's contracture in children: aetiology and prevention. MSK
M 1
D
81 31855367
Parameswaran P
HLA B27 Syndromes MSK
E
82 30285395
Merryman J
Klumpke Palsy MSK
E
83 30571026
Justiz Vaillant AA
Systemic Lupus Erythematosus MSK
E
84 29083622
Lowe D
Alkaline Phosphatase MSK
E
85 29083669
Masiewicz S
Posterior Hip Dislocation MSK
E
85 matches found
Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options